Search Sort by Newest to OldestOldest to NewestRelevanceA-ZZ-A Pagination First page First Previous page ‹ Page 1 Current page 2 2022 M&A in Review: Regaining Momentum With 17 announced transactions, the fourth quarter of 2022 was one of the most active quarters we have seen since the COVID-19 pandemic began near the end of Q1 2020. Four of the 17... Research Report M&A Quarterly Activity Report: Q1 2023 Hospital and Health System Transactions In the final quarter of 2022, we noted an uptick in transaction activity with 17 announced transactions. That activity level was almost matched... Research Report Summer 2023 Kaufman Hall Report: Strategic Alternatives for Health System Outreach Laboratories The latest Kaufman Hall Report includes an inside look at the strategic alternatives for health system outreach laboratories—and key challenges and opportunities for health systems. Research Report M&A Quarterly Activity Report: Q2 2023 A significant increase in the number of announced transactions in Q2 2023—20, as compared to 15 transactions announced in Q1 2023—brought the quarter in line with pre-pandemic activity levels. Research Report M&A Quarterly Activity Report: Q3 2023 With 18 announced transactions, Q3 2023 continued the momentum in activity we have seen throughout the year. A high percentage of financially distressed organizations in this quarter’s transactions reflected the impact of challenging operational and financial headwinds. Research Report 2023 Hospital and Health System M&A in Review Financial distress emerged as a key factor in hospital and health system M&A in 2023, with 28% of announced transactions involving a financially distressed partner. This is almost double the percentage of transactions in which financial distress was cited as a factor in 2022. Research Report M&A Quarterly Activity Report: Q1 2024 The 20 transactions announced in Q1 2024 continued a steady climb out of the slowdown in activity experienced during the Covid pandemic, significantly exceeding the number of transactions announced in Q1 of 2021, 2022, and 2023. Research Report Pagination First page First Previous page ‹ Page 1 Current page 2
2022 M&A in Review: Regaining Momentum With 17 announced transactions, the fourth quarter of 2022 was one of the most active quarters we have seen since the COVID-19 pandemic began near the end of Q1 2020. Four of the 17... Research Report
M&A Quarterly Activity Report: Q1 2023 Hospital and Health System Transactions In the final quarter of 2022, we noted an uptick in transaction activity with 17 announced transactions. That activity level was almost matched... Research Report
Summer 2023 Kaufman Hall Report: Strategic Alternatives for Health System Outreach Laboratories The latest Kaufman Hall Report includes an inside look at the strategic alternatives for health system outreach laboratories—and key challenges and opportunities for health systems. Research Report
M&A Quarterly Activity Report: Q2 2023 A significant increase in the number of announced transactions in Q2 2023—20, as compared to 15 transactions announced in Q1 2023—brought the quarter in line with pre-pandemic activity levels. Research Report
M&A Quarterly Activity Report: Q3 2023 With 18 announced transactions, Q3 2023 continued the momentum in activity we have seen throughout the year. A high percentage of financially distressed organizations in this quarter’s transactions reflected the impact of challenging operational and financial headwinds. Research Report
2023 Hospital and Health System M&A in Review Financial distress emerged as a key factor in hospital and health system M&A in 2023, with 28% of announced transactions involving a financially distressed partner. This is almost double the percentage of transactions in which financial distress was cited as a factor in 2022. Research Report
M&A Quarterly Activity Report: Q1 2024 The 20 transactions announced in Q1 2024 continued a steady climb out of the slowdown in activity experienced during the Covid pandemic, significantly exceeding the number of transactions announced in Q1 of 2021, 2022, and 2023. Research Report